New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Checkpoint Therapeutics, Inc.
CKPT
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

163M

Biotechnology

Next Earning date - 11 Nov 2024

163M

Biotechnology

Next Earning date - 11 Nov 2024

3.67USD
Shape0.23Ā ( 6.69%)
favorite-chart

Relative Strenght

19
favorite-chart

Volume Buzz

201%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

1%

Quote Panel

Shape
Updated October 28, 2024
1W 16.14 % 1M 63.84 % 3M 51.65 % 1Y 94.18 %

Key Metrics

Shape
  • Market Cap

    162.65M


  • Shares Outstanding

    44.32M


  • Share in Float

    37.36M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    3.67


  • Average Volume

    469073


  • Beta

    1.302


  • Range

    1.36-3.69


  • Industry

    Biotechnology


  • Website

    https://www.checkpointtx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2085.21x

P/S Ratio

-8.51x

P/B Ratio

0.0

Debt/Equity

-54444.9%

Net Margin

$-1.7

EPS

How CKPT compares to sector?

P/E Ratio

Relative Strength

Shape

CKPT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$52M

Shape126579%

2025-Revenue

$0.48

Shape-167%

2025-EPS

$52M

Shape-678%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

B. Riley

initialise

Previous: Not converted

2021-06-09

Now: Buy

Cantor Fitzgerald

initialise

Previous: Not converted

2021-01-22

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.20
vsĀ -1.40

Q4.22

arrow
arrow

N/A

-2.47
vsĀ -3.79

Q1.23

arrow
arrow

N/A

-0.89
vsĀ -2.00

Q2.23

arrow
arrow

N/A

-1.05
vsĀ -1.60

Q3.23

arrow
arrow

N/A

-0.29
vsĀ -1.20

Q4.23

arrow
arrow

N/A

-1.10
vsĀ -2.47

Q1.24

arrow
arrow

N/A

-0.33
vsĀ -0.89

Q2.24

arrow
arrow

N/A

-0.18
vsĀ -1.05

Q3.24

arrow
arrow

N/A

-0.15
vsĀ -0.29

Q4.24

arrow
arrow

N/A

-0.16
vsĀ -1.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+66%

48KĀ  vsĀ 29K

Q4.22

arrow
arrow

+363%

74KĀ  vsĀ 16K

Q1.23

arrow
arrow

-33%

35KĀ  vsĀ 52K

Q2.23

arrow
arrow

+72%

31KĀ  vsĀ 18K

Q3.23

arrow
arrow

-35%

31KĀ  vsĀ 48K

Q4.23

arrow
arrow

-92%

6KĀ  vsĀ 74K

Q1.24

arrow
arrow

-100%

NAĀ  vsĀ 35K

Q2.24

arrow
arrow

+32%

41KĀ  vsĀ 31K

Q3.24

arrow
arrow

-34%

20.3KĀ  vsĀ 31K

Q4.24

arrow
arrow

+239%

20.3KĀ  vsĀ 6K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+787%

7.87
vsĀ -1.89

Q4.22

arrow
arrow

+130%

1.3
vsĀ 7.87

Q1.23

arrow
arrow

+13%

0.13
vsĀ 1.3

Q2.23

arrow
arrow

+71%

0.71
vsĀ 0.13

Q3.23

arrow
arrow

+30%

0.3
vsĀ 0.71

Q4.23

arrow
arrow

+147%

1.47
vsĀ 0.3

Q1.24

arrow
arrow

+107%

1.07
vsĀ 1.47

Q2.24

arrow
arrow

+42%

0.42
vsĀ 1.07

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

70

70
vsĀ 61

15%

Q2.21

arrow
arrow

73

73
vsĀ 70

4%

Q3.21

arrow
arrow

68

68
vsĀ 73

-7%

Q4.21

arrow
arrow

67

67
vsĀ 68

-1%

Q1.22

arrow
arrow

72

72
vsĀ 67

7%

Q2.22

arrow
arrow

61

61
vsĀ 72

-15%

Q3.22

arrow
arrow

58

58
vsĀ 61

-5%

Q1.23

arrow
arrow

1

1
vsĀ NA

NA

Earnings Growth

Latest News